Increased T-Helper-1-Type Immunity and Decreased T-Helper-2-Type Immunity in Patients with Preeclampsia
Corresponding Author
Shigeru Saito
Department of Obstetrics and Gynecology, Toyama Medical and Pharmaceutical University, Toyama, Japan
Department of Obstetrics and Gynecology, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama-shi, Toyama, 930–0194, Japan.Search for more papers by this authorHideshi Umekage
Department of Obstetrics and Gynecology, Nara Medical University, Nara, Japan
Search for more papers by this authorYoshiharu Sakamoto
Department of Obstetrics and Gynecology, Nara Medical University, Nara, Japan
Search for more papers by this authorMasatoshi Sakai
Department of Obstetrics and Gynecology, Toyama Medical and Pharmaceutical University, Toyama, Japan
Search for more papers by this authorKyoko Tanebe
Department of Obstetrics and Gynecology, Toyama Medical and Pharmaceutical University, Toyama, Japan
Search for more papers by this authorYasushi Sasaki
Department of Obstetrics and Gynecology, Toyama Medical and Pharmaceutical University, Toyama, Japan
Search for more papers by this authorHajime Morikawa
Department of Obstetrics and Gynecology, Nara Medical University, Nara, Japan
Search for more papers by this authorCorresponding Author
Shigeru Saito
Department of Obstetrics and Gynecology, Toyama Medical and Pharmaceutical University, Toyama, Japan
Department of Obstetrics and Gynecology, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama-shi, Toyama, 930–0194, Japan.Search for more papers by this authorHideshi Umekage
Department of Obstetrics and Gynecology, Nara Medical University, Nara, Japan
Search for more papers by this authorYoshiharu Sakamoto
Department of Obstetrics and Gynecology, Nara Medical University, Nara, Japan
Search for more papers by this authorMasatoshi Sakai
Department of Obstetrics and Gynecology, Toyama Medical and Pharmaceutical University, Toyama, Japan
Search for more papers by this authorKyoko Tanebe
Department of Obstetrics and Gynecology, Toyama Medical and Pharmaceutical University, Toyama, Japan
Search for more papers by this authorYasushi Sasaki
Department of Obstetrics and Gynecology, Toyama Medical and Pharmaceutical University, Toyama, Japan
Search for more papers by this authorHajime Morikawa
Department of Obstetrics and Gynecology, Nara Medical University, Nara, Japan
Search for more papers by this authorAbstract
PROBLEM: To examine whether preeclampsia involves type-1 T-helper (Th1) immune hyperactivity.
METHOD OF STUDY: Expression of HLA-DR, a cell-surface marker of activation, was analyzed on CD3+, CD4+, and CD8+ T cells in 15 preeclamptic patients and 15 normal pregnant women using flow cytometry. Additionally, peripheral blood mononuclear cells from preeclamptic patients and normal pregnant women were cultured with or without phytohemagglutinin (PHA) stimulation, and interleukin (IL)-2, IL-4, interferon (IFN)-Γ, and tumor necrosis factor (TNF)-α concentrations were determined in the supernatant by immunoassays.
RESULTS: HLA-DR antigen was expressed more strongly on CD3+ T cells in preeclamptic patients than in normal subjects. In preeclampsia, HLA-DR was expressed more strongly in CD8+ T cells than in CD4+ T cells. More TNF-α, IL-2, and IFN-γ were produced by unstimulated and stimulated cultured peripheral blood mononuclear cells from preeclampsia patients than by those from normal subjects. TNF-α/IL-4, IL-2/IL-4, and IFN-γ/IL-4 ratios were higher in preeclamptic patients than in the normal group. Significant positive correlations were observed between mean blood pressure and concentrations of the Th-1 type cytokines IL-2, IFN-γ, and TNF-α.
CONCLUSION: Up-regulation of Th1 responses and down-regulation of Th2 responses occur in preeclampsia.
REFERENCES
- 1 Wegmann TG, Lin H., Guilbert L., Mosmann TL: Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14: 353–358.
- 2 Lin H., Mosmann TR, Guilbert L., Tuntipopipat S., Wegmann TG: Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151: 4562–4573.
- 3 Delassus S., Coutinho GC, Saucier C., Darche S., Kourilsky P.: Differential cytokine expression in maternal blood and placenta during murine gestation. J Immunol 1994; 152: 2411–2420.
- 4 Tangri S., Wegmann TG, Lin H., Raghupathy R.: Maternal anti-placental reactivity in natural, immunologicallymediated fetal resorptions. J Immunol 1994; 152: 4903–4911.
- 5 Chaouat G., Meliani AA, Martal J., Raghupathy R., Elliot J., Mosmann T., Wegmann T.: IL-10 prevents naturally occuring fetal loss in the CBAxDBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is occured by in vivo injection of IFN-t. J Immunol 1994; 154: 4261–4268.
- 6 Krishnan L., Guilbert LJ, Russell AS, Wegmann TG, Mosmann TG, Belosevic M.: Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN responses and increased production of T helper 2 cytokines. J Immunol 1996; 156: 644–652.
- 7 Krishnan L., Guilbert LJ, Wegmann TG, Belosevic M., Mosmann TR: T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. J Immunol 1996; 156: 653–662.
- 8 Vince GS, Johnson PM: Is there a Th2 bias in human pregnancy? J Reprod Immunol 1996; 32: 101–104.
- 9 Guilbert LJ: There is a bias against type1 (inflammatory) cytokine expression and function in pregnancy. J Reprod Immunol 1996; 32: 105–110.
- 10 Kelly RW, Critchley HOD: A T helper-2 bias in decidua: the prostaglandin contribution of macrophage and trophoblast. J Reprod Immunol 1997; 33: 181–187.
- 11 Marzi M., Vigano A., Trabattoni D., Villa ML, Salvaggio A., Clerici E., Clerici M.: Characterization of type1 and type2 cytokine profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106: 127–133.
- 12 Krasnow JS. Tollerud DJ, De Loia JA: Endometrial Th2 cytokine expression throughout the menstrual cycle and early pregnancy. Hum Reprod 1996; 11: 1747–1754.
- 13 Sabahi F., Rola-Plesczcynski M., O'Connell S., Frenkel LD: Qualitative and quantitative analysis of T lymphocytes during normal human pregnancy. Am J Reprod Immunol 1995; 33: 381–392.
- 14 Jones CA, Finlay-Jones JJ, Hart PH: Type-1 and type-2 cytokines in human late-gestation decidual tissue. Biol Reprod 1997; 57: 303–311.
- 15 Ekerfelt C., Matthiesen L., Berg G., Ernerudh J.: Paternal leukocytes selectively increase secretion of IL-4 in peripheral blood during normal pregnancies: Demonstrated by a novel one-way MLC measuring cytokine secretion. Am J Reprod Immunol 1997; 38: 320–326.
- 16 Russell AS, Johnston C., Chew C., Maksymowych WP: Evidence for reduced Th1 function in normal pregnancy: A hypothesis for the remission of rheumatoid arthritis. J Rheumatol 1997; 24: 1045–1050.
- 17 Sunder-Plassmann G., Derffer K., Wagner L., Stockenhuber F., Endler M., Nowotny C., Balcke P.: Increased serum activity of interleukin-2 in patients with preeclampsia. J Autoimmunol 1989; 2: 203–205.
- 18 Meekins JW, McLaughlin PJ, West DC, McFadyen IR, Johnson PM: Endothelial cell activation by tumor necrosis factor-alpha (TNFα) and the development of preeclampsia. Clin Exp Immunol 1994; 98: 110–114.
- 19 Vince GS, Starkey PM, Austgulen R., Kwiatkowski D., Redman CWG: Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with preeclampsia. Br J Obstet Gynecol 1995; 102: 20–25.
- 20 Kupfermine MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML: Tumor necrosis factor-α is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170: 1752–1759.
- 21 Dudley DJ, Hunter C., Mitchell MD. Varner MW, Gately M.: Elevations of serum interleukin-12 concentrations in women with severe preeclampsia and HELLP syndrome. J Reprod Immunol 1996; 31: 97–107.
- 22 Daniel Y., Kupfermine MJ, Baram A., Jaffa AJ, Fait G., Wolman I., Lessing JB: Plasma interleukin-12 is elevated in patients with preeclampsia. Am J Reprod Immunol 1998; 39: 376–380.
- 23 Omu AE, Makhseed M. Al-Qattan F.: The comparative value of interleukin-4 in sera of women with preeclampsia and cord sera. Nutrition 1995; 11: 688–691.
- 24 Sacks GP, Scott D., Tivnann H., Mire-Sluis T., Sargent IL, Redman CWG: Interleukin-12 and preeclampsia. J Reprod Immunol 1997; 34: 155–158.
- 25 Saito S., Morii T., Umekage H., Makita K., Nishikawa K., Narita N., Ichijo M., Morikawa H., Ishii N., Nakamura M., Sugamura K.: Expression of the interleukin-2 receptor chain on cord blood mononuclear cells. Blood 1996; 87: 3344–3350.
- 26 Saito S., Saito M., Kato Y., Maruyama M., Moriyama I., Ichijo M.: Production of IL- 6 (BSF-2/ IFNβ2) by mononuclear cells in premature and term infants. J Reprod Immunol 1990; 17: 17–26.
- 27 Marinoni E., Pita OD, Bresadole M. Ippoliti F., Iorio RD: Cell mediated immunity imbalance in pregnancy-induced hypertension. Gynecol Obstet Invest 1994; 38: 236–240.
- 28 Neßelhut T., Hinney B., Rath W., Balwanz A. Cillen N., Kuhn W.: The changes of the immunological basic parameters interleukin-2 receptor and CD8 antigen in preeclampsia. Z Geburtsh u Perinat 1992: 196: 63–66.
- 29 Mosmann TR, Cherwinski H., Bond MW, Gieldlin MA. Coffman RL: Two types of murine helper T cell clone Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986: 136: 2348–2357.
- 30 Yui J., Garcia-Lloret M. Wegmann TG, Guilbert LJ: Cytotoxity of tumor necrosis factor-α and γ-interferon against primary human placental trophoblasts. Placenta 1994; 15: 819–835.
- 31 Yui J., Hemmings D., Garcia-Lloret M., Guilbert LJ: Expression of the human p55 and p75 tumor necrosis factor receptors in primary villous trophoblasts and their role in cytotoxic signal transduction. Biol Reprod 1996; 55: 400–409.
- 32 Vertani T., Abbate M., Zoja C.: Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol 1989; 134: 419–430.
- 33 Yoshizumi M., Perrella MA, Burnett Jr JC, Lee MET: Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shorting its half-life. Circ Res 1993; 73: 205–209.
- 34 Ishii Y., Partridge CA, Vecehio PJ, Malik AB: Tumor necrosis factor-α mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2. J Clin Invest 1992; 89: 794–802.
- 35 King A., Loke YW: Human trophoblast and JEG choriocarcinoma cells are sensitive to lysis by IL-2 stimulated decidual natural killer cells. Cell Immunol 1990; 129: 435–441.
- 36 Saito S., Morii T., Enomoto M., Sakakura S., Nishikawa K., Narita N., Ichijo M.: The effect of interleukin-2 and transforming growth factor-β2 (TGF β2) on the proliferation and natural killer activity of decidual CD16-CD56bright natural killer cells. Cell Immunol 1993; 152: 605–613.
- 37 Cignetti M., Garzetti GG, Marchegiani F., Fabris N., Romanini C.: Natural killer cells and Tac antigen in the hypertension of pregnancy. Clin Exp Obst Gyn 1990; 17: 13–15.
- 38 Alanen A., Lassila O.: Deficient natural killer cell function in preeclampsia. Obstet Gynecol 1982; 60: 631–634.
- 39 Zou Y., Damsky CH, Ciu K., Roberts JM, Fisher SJ: Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest 1993; 91: 950–960.
- 40 Hamai Y., Fujii T., Yamashita T., Kozuma Y., Okai T., Taketani Y.: Pathogenetic implication of interleukin-2 expressed in preeclamptic decidual tissues: A possible mechanism of deranged vasculature of the placenta associated with preeclampsia. Am J Reprod Immunol 1997; 38: 83–88.
- 41 Hamai Y., Fujii T., Tamashita T., Nishina H., Kozuma S., Mikami Y., Taketani Y.: Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-α levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 1997; 38: 89–93.
- 42 Taylor RN: Review: Immunology of preeclampsia. Am J Reprod Immunol 1997; 37: 79–86.
- 43 Barrat F., Lesourd B., Boulouis HJ, Thibault D., Vincent-Naulleau S., Gjata B., Louise A., Neway T., Pilet C.: Sex and parity modulate cytokine production during murine aging. Clin Exp Immunol 1997; 109: 562–568.
